@article{TBCR68480,
author = {Qingyuan Zhang and Quchang Ouyang and Wei Li and Joanne Chiu and Min Yan and Yen-Shen Lu and Sanyuan Sun and Huiping Li and Yingying Du and Xujuan Wang and Tao Sun and Yongmei Yin and Haibo Wang and Feng Ye and Kunwei Shen and Jingfen Wang and Yueyin Pan and Shusen Wang and Jin Yang and Xiaohong Wu and Ming-Shen Dai and Jing Cheng and Yuee Teng and Fang Su and Xinhong Wu and Jingdong He and Peifen Fu and Lulu Yang and Yuan Xin and Xiaojia Wang and Zefei Jiang},
title = {Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study},
journal = {Translational Breast Cancer Research},
volume = {3},
number = {0},
year = {2022},
keywords = {},
abstract = {},
issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/68480}
}